IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice.
暂无分享,去创建一个
M. Konstan | T. Bonfield | D. Dawson | J. Hilliard | M. Berger | J. Chmiel | J. E. Knesebeck | Tracey L. Bonfield | Melvin Berger | Deborah V. Dawson | Jeanne E. Knesebeck
[1] A J Ratner,et al. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. , 1998, The Journal of clinical investigation.
[2] S. Garg,et al. Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis. , 1998, Critical care medicine.
[3] A. Pahl,et al. Modulation of transcription factor NF‐κB by enantiomers of the nonsteroidal drug ibuprofen , 1998, British journal of pharmacology.
[4] M. Hanes,et al. Microbial Pathogenesis in Cystic Fibrosis: Pulmonary Clearance of Mucoid Pseudomonas aeruginosa and Inflammation in a Mouse Model of Repeated Respiratory Challenge , 1998, Infection and Immunity.
[5] M. Konstan,et al. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. , 1997, The Journal of clinical investigation.
[6] A. Lentsch,et al. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. , 1997, The Journal of clinical investigation.
[7] D. Corry,et al. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. , 1997, Journal of immunology.
[8] Melvin Berger,et al. Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology , 1997, Pediatric pulmonology.
[9] T. Noah,et al. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. , 1997, The Journal of infectious diseases.
[10] M. Kemna,et al. Reduced IL‐10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR) , 1996, Clinical and experimental immunology.
[11] M. Burdick,et al. The Association between Mortality Rates and Decreased Concentrations of Interleukin-10 and Interleukin-1 Receptor Antagonist in the Lung Fluids of Patients with the Adult Respiratory Distress Syndrome , 1996, Annals of Internal Medicine.
[12] S. Wenzel,et al. Interleukin-10 regulation in normal subjects and patients with asthma. , 1996, Journal of Allergy and Clinical Immunology.
[13] I. Siegler,et al. Approaches to the nonparametric analysis of limited longitudinal data sets. , 1996, Experimental aging research.
[14] M. Konstan,et al. Inflammatory cytokines in cystic fibrosis lungs. , 1995, American journal of respiratory and critical care medicine.
[15] M. Konstan,et al. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. , 1995, American journal of respiratory cell and molecular biology.
[16] T. Standiford,et al. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. , 1995, Journal of immunology.
[17] D. Leduc,et al. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. , 1995, The Journal of clinical investigation.
[18] C. Morissette,et al. Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice , 1995, Infection and immunity.
[19] Peng Wang,et al. Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.
[20] P. Ward,et al. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. , 1995, Journal of immunology.
[21] D. Riches,et al. Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.
[22] D. Schidlow,et al. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. , 1995, The Journal of pediatrics.
[23] P. J. Byard,et al. Effect of high-dose ibuprofen in patients with cystic fibrosis. , 1995, The New England journal of medicine.
[24] J. Cidlowski,et al. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors , 1995, Molecular and cellular biology.
[25] P. Ward,et al. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. , 1993, Journal of immunology.
[26] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[27] M. Konstan,et al. Infection and inflammation of the lung in cystic fibrosis , 1993 .
[28] T. Mosmann,et al. IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.
[29] M. Konstan,et al. Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis. , 1990, The American review of respiratory disease.
[30] C. Langston,et al. A Mouse Model of Chronic Pulmonary Infection with Pseudomonas aeruginosa and Pseudomonas cepacia , 1987, Pediatric Research.
[31] R. Crystal,et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. , 1986, Journal of applied physiology.
[32] H. Colten,et al. ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSIS , 1985, The Lancet.
[33] R. A. Groeneveld,et al. Practical Nonparametric Statistics (2nd ed). , 1981 .
[34] J. A. Bass,et al. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. , 2015, The American review of respiratory disease.
[35] Malay Ghosh,et al. Nonparametric Methods in Longitudinal Studies , 1973 .
[36] W. J. Conover,et al. Practical Nonparametric Statistics , 1972 .
[37] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.